Next Generation News and Research

RSS

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.

3 Nov 2021

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

Cancer is the second leading cause of death in New York State after heart disease among adults and the second cause of death among children after injuries. And the number of people diagnosed with the disease increases every year.

2 Nov 2021

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related to self-control and mental flexibility by merging artificial intelligence with targeted electrical brain stimulation.

1 Nov 2021

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.

31 Oct 2021

Harnessing the genetics of hookworms to develop next generation of PPE for combat troops

Researchers at Washington University School of Medicine in St. Louis have received a grant to develop the next generation of personal protective equipment (PPE) for combat troops.

30 Oct 2021

CDC: Blood lead reference value for children updated

The Centers for Disease Control and Prevention (CDC) recently updated its blood lead reference value (BLRV) from 5 µg/dL to 3.5 µg/dL in response to the Lead Exposure Prevention and Advisory Committee (LEPAC) recommendation made on May 14, 2021.

30 Oct 2021

CDC announces $26 million to develop next-generation infectious disease forecasting and analytics

The Centers for Disease Control and Prevention (CDC) today announced $26 Million in funding to develop next-generation infectious disease forecasting and analytics.

30 Oct 2021

A new approach to selectively turn on gene therapies in target cells

Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells.

28 Oct 2021

Malaria: An Interview with the World Health Organization

In this interview, we spoke to Dr. Akpaka Kalu, the World Health Organization's team leader for malaria in Africa, about the groundbreaking malaria vaccine rollout announcement.

28 Oct 2021

New mechanisms for treating impregnable KRAS mutant cancers with statins

Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent years, giving hopes to many researchers and patients.

27 Oct 2021

Research reveals the microbial landscape of patients with systemic lupus erythematosus

Systemic lupus erythematosis (SLE) is an autoimmune disease in which the immune system targets tissues of the body, causing widespread inflammation and affecting multiple organs such as the kidney and the brain.

27 Oct 2021

Home care patients with language barriers may be vulnerable to poor outcomes

Patients with language barriers who are receiving home health care are at an increased risk for hospital readmission, according to a new study published in the International Journal of Nursing Studies.

27 Oct 2021

ioSkeletal Myocytes | New product launch

bit.bio has today launched a new product, ioSkeletal Myocytes.

From bit.bio 27 Oct 2021

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

Today bit.bio welcomed three new members to its Board of Directors, who bring their respective experience of turning world-class science into new industries.

From bit.bio 27 Oct 2021

New study explains why Delta is so easily transmitted and infects people quickly

The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months. A new study from Boston Children's Hospital, published today in Science, explains why Delta is so easily spread and infects people so quickly, and suggests a more targeted strategy for developing future COVID-19 vaccines and treatments.

27 Oct 2021

Next Generation News and Research

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

Harnessing the genetics of hookworms to develop next generation of PPE for combat troops

CDC: Blood lead reference value for children updated

CDC announces $26 million to develop next-generation infectious disease forecasting and analytics

A new approach to selectively turn on gene therapies in target cells

Malaria: An Interview with the World Health Organization

New mechanisms for treating impregnable KRAS mutant cancers with statins

Research reveals the microbial landscape of patients with systemic lupus erythematosus

Home care patients with language barriers may be vulnerable to poor outcomes

ioSkeletal Myocytes | New product launch

bit.bio expands Board of Directors with appointment of entrepreneurs and Nobel Laureate

New study explains why Delta is so easily transmitted and infects people quickly

DOD funds first human trial of a device to enhance the natural brain cleansing system

WVU-led project will leverage AI and digital health to address healthcare costs and disparities

Case Western Reserve secures $16 million to understand the relation between substance use and HIV

U of M Udall Center receives $11.3 million grant to continue research on deep brain stimulation for Parkinson’s disease

A new vaccine approach that could prevent future pandemics

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News